Real-time index price for TSX Composite Index (TXCX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here’s what doctors think ...

Treatments like GLP-1s are effective, but they're also extremely expensive. With GLP-1s rising in demand, it can pose a ...

Weight loss with Ozempic or Wegovy can be effective, but expensive. Enter so-called GLP-1 supplements that have taken on the ...

Bre Teamer chats with Dr. Alex Zayid of Icon Anti-Aging about recent developments and research that supports using ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

Jefferies biotech analyst Michael Yee joins Market Domination to lay out his bull case on Gilead (GILD) and how investors should consider their biotech positions relative to the GLP-1 weight-loss ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Jefferies biotech analyst Michael Yee joins Market Domination to lay out his bull case on Gilead (GILD) and how investors should consider their biotech positions relative to the GLP-1 weight-loss ...

Jefferies biotech analyst Michael Yee joins Market Domination to lay out his bull case on Gilead (GILD) and how investors should consider their biotech positions relative to the GLP-1 weight-loss ...

Let's consider two stocks trading well below $200 that have what it takes to do that: Novo Nordisk (NYSE: NVO) and DexCom ...